Analysts Estimate Medifast (MED) to Report a Decline in Earnings: What to Look Out for

Company Overview - Medifast (MED) is anticipated to report a year-over-year decline in earnings due to lower revenues, with a consensus estimate indicating a quarterly loss of $0.76 per share, representing a significant change of -860% compared to the previous year [3][12] - Revenues for the upcoming quarter are expected to be $70.81 million, reflecting a decrease of 40.5% from the same quarter last year [3] Earnings Expectations - The earnings report is scheduled for release on February 17, and the stock may experience upward movement if the reported numbers exceed expectations, while a miss could lead to a decline [2] - The consensus EPS estimate has been revised 40% higher in the last 30 days, indicating a reassessment by analysts [4] Earnings Surprise Prediction - The Zacks Earnings ESP (Expected Surprise Prediction) model shows that the Most Accurate Estimate for Medifast aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [12] - Despite a Zacks Rank of 2 (Buy), the combination of a 0% Earnings ESP makes it challenging to predict a positive earnings surprise for Medifast [12] Historical Performance - In the last reported quarter, Medifast was expected to post a loss of $0.01 per share but instead reported a loss of -$0.21, resulting in a surprise of -2,000% [13] - Over the past four quarters, Medifast has only beaten consensus EPS estimates once [14] Industry Context - In comparison, US Foods (USFD), a player in the Zacks Food - Miscellaneous industry, is expected to post earnings of $1 per share for the same quarter, indicating a year-over-year increase of +19.1% [18] - US Foods' revenue is projected to be $9.86 billion, up 3.9% from the previous year, with a positive Earnings ESP of +1.13% and a Zacks Rank of 3 (Hold), suggesting a higher likelihood of beating the consensus EPS estimate [19][20]